Nutescu EA[au] - Search Results

Year	Number of Results
2002	1
2003	5
2004	14
2005	8
2006	10
2007	10
2008	8
2009	4
2010	6
2011	8
2012	4
2013	17
2014	10
2015	9
2016	8
2017	7
2018	4
2019	7
2020	5
2021	6
2022	3
2023	3

1

Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.

Nutescu EA, Spinler SA, Wittkowsky A, Dager WE. Nutescu EA, et al. Ann Pharmacother. 2009 Jun;43(6):1064-83. doi: 10.1345/aph.1L194. Epub 2009 May 19. Ann Pharmacother. 2009. PMID: 19458109 Review.

2

Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.

Kim K, Duarte JD, Galanter WL, Han J, Lee JC, Cavallari LH, Nutescu EA. Kim K, et al. Among authors: nutescu ea. Pharmacogenomics. 2023 May 11. doi: 10.2217/pgs-2023-0014. Online ahead of print. Pharmacogenomics. 2023. PMID: 37166395

3

Pharmacology of anticoagulants used in the treatment of venous thromboembolism.

Nutescu EA, Burnett A, Fanikos J, Spinler S, Wittkowsky A. Nutescu EA, et al. J Thromb Thrombolysis. 2016 Jan;41(1):15-31. doi: 10.1007/s11239-015-1314-3. J Thromb Thrombolysis. 2016. PMID: 26780737 Free PMC article. Review.

4

Implementation of inpatient models of pharmacogenetics programs.

Cavallari LH, Lee CR, Duarte JD, Nutescu EA, Weitzel KW, Stouffer GA, Johnson JA. Cavallari LH, et al. Among authors: nutescu ea. Am J Health Syst Pharm. 2016 Dec 1;73(23):1944-1954. doi: 10.2146/ajhp150946. Am J Health Syst Pharm. 2016. PMID: 27864202 Free PMC article. Review.

5

Warfarin pharmacogenetics: to genotype or not to genotype, that is the question.

Cavallari LH, Nutescu EA. Cavallari LH, et al. Among authors: nutescu ea. Clin Pharmacol Ther. 2014 Jul;96(1):22-4. doi: 10.1038/clpt.2014.78. Clin Pharmacol Ther. 2014. PMID: 24942399 Review.

6

Changes in the USP heparin monograph and implications for clinicians.

Smythe MA, Nutescu EA, Wittkowsky AK. Smythe MA, et al. Among authors: nutescu ea. Pharmacotherapy. 2010 May;30(5):428-31. doi: 10.1592/phco.30.5.428. Pharmacotherapy. 2010. PMID: 20411994 No abstract available.

7

New anticoagulant agents: direct thrombin inhibitors.

Nutescu EA, Shapiro NL, Chevalier A. Nutescu EA, et al. Cardiol Clin. 2008 May;26(2):169-87, v-vi. doi: 10.1016/j.ccl.2007.12.005. Cardiol Clin. 2008. PMID: 18406993 Review.

8

Implementation of pharmacogenomics into inpatient general medicine.

Chen T, O'Donnell PH, Middlestadt M, Ruhnke GW, Danahey K, van Wijk XMR, Choksi A, Knoebel R, Hartman S, Yeo KJ, Friedman PN, Ratain MJ, Nutescu EA, O'Leary KJ, Perera MA, Meltzer DO. Chen T, et al. Among authors: nutescu ea. Pharmacogenet Genomics. 2023 Feb 1;33(2):19-23. doi: 10.1097/FPC.0000000000000487. Epub 2022 Dec 9. Pharmacogenet Genomics. 2023. PMID: 36729768

9

The future of anticoagulation clinics.

Nutescu EA. Nutescu EA. J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):61-3. doi: 10.1023/B:THRO.0000014595.46367.89. J Thromb Thrombolysis. 2003. PMID: 14760214 Review.

10

Anticoagulation management services: entering a new era.

Nutescu EA. Nutescu EA. Pharmacotherapy. 2010 Apr;30(4):327-9. doi: 10.1592/phco.30.4.327. Pharmacotherapy. 2010. PMID: 20334452 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year